Bharat Biotech’s intranasal Covid vaccine approved, to be available on CO-WIN from Friday
As Covid makes a resurgence in parts of the world driven by a new Omicron sub-variant, India too is updating its pandemic playbook.
Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday.
The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening, they ..
The nasal vaccine — BBV154 — received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
According to Bharat Biotech, the intranasal vaccine has several advantages because the nasal route has excellent potential for vaccination due to the organized immune systems of the nasal mucosa. It is also non-invasive and needle-free and has ease of administration since it does not require ..
Read more at: ECONOMIC TIMES